Učitavanje...
Using proteomics as a powerful tool to develop a vaccine against Mediterranean visceral leishmaniasis
Visceral leishmaniasis (VL) is a tropical infectious disease, which is called Mediterranean visceral leishmaniasis (MVL) in the Mediterranean area. In spite of many attempts, no effective commercial vaccine exists for MVL. To find new targets for developing antileishmanial vaccines, knowing parasite...
Spremljeno u:
| Izdano u: | J Parasit Dis |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer India
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5962495/ https://ncbi.nlm.nih.gov/pubmed/29844618 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12639-018-0986-y |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|